The Value of Using Mini-oral Pulse Steroid Therapy Along With Non Cultured Epidermal Cell Suspension (NCES) in Stable Resistant Vitiligo

ConditionVitiligo
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCairo University

About this trial

Assessing the additive value of mini-oral pulse steroid therapy in surgical treatment of acral and difficult to treat sites of vitiligo

Eligibility criteria

Qualifiers

Patients with non-segmental vitiligo (NSV) with acral or resistant lesions over the elbows and knees, that has not responded to conventional treatment

Stability for ≥ 1 year

Age ≥18 years

Lack of topical treatment for at least 1 month prior to surgery and systemic treatment for at least 3 months prior to surgery.

Disqualifiers

Non acral NSV responsive to conventional treatment modalities

Active vitiligo; new lesions, expansion of old lesions, confetti like lesions, ill-defined edges or koebnerization in < 1 year

Age < 18 years.

Pregnant females.

Trial design

Treatments tested in this trial

  • oral steroid-dexamethasone
  • non cultured epidermal suspension

Treatment groups

40 Participants
are divided into 2 treatment groups

Sponsors and collaborators